BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnes EL, Loftus EV Jr, Kappelman MD. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. Gastroenterology 2021;160:677-89. [PMID: 33098884 DOI: 10.1053/j.gastro.2020.08.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Sedano R, Hogan M, Mcdonald C, Aswani-omprakash T, Ma C, Jairath V. Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab362] [Reference Citation Analysis]
2 Suzuki Y, Monteiro RC, Coppo R, Suzuki H. The Phenotypic Difference of IgA Nephropathy and its Race/Gender-dependent Molecular Mechanisms. Kidney360 2021;2:1339-48. [PMID: 35369654 DOI: 10.34067/KID.0002972021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chang ML, Yang Z, Yang SS. Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression. Int J Mol Sci 2020;21:E8308. [PMID: 33167521 DOI: 10.3390/ijms21218308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pinton P. Combination of vedolizumab and immunomodulators in ulcerative colitis. J Gastroenterol Hepatol 2021;36:3556. [PMID: 34519096 DOI: 10.1111/jgh.15686] [Reference Citation Analysis]
5 Kuźnicki P, Neubauer K. Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse. J Clin Med 2021;10:4623. [PMID: 34640641 DOI: 10.3390/jcm10194623] [Reference Citation Analysis]
6 Li G, Zhang J, Van Spall HGC, Douglas PS, Wang Y, Sun X, Thabane L. Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey. Diabetologia 2022. [PMID: 35705796 DOI: 10.1007/s00125-022-05736-z] [Reference Citation Analysis]
7 Sasegbon A, Vasant DH. Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach. Neurogastroenterol Motil 2021;33:e14152. [PMID: 33835634 DOI: 10.1111/nmo.14152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Daniel R, Jimenez J, Pall H. Health Equity and Social Determinants of Health in Pediatric Gastroenterology. Pediatr Clin North Am 2021;68:1147-55. [PMID: 34736581 DOI: 10.1016/j.pcl.2021.07.004] [Reference Citation Analysis]
9 Uche-Anya E, Anyane-Yeboa A, Berzin TM, Ghassemi M, May FP. Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity. Gut 2022:gutjnl-2021-326271. [PMID: 35688612 DOI: 10.1136/gutjnl-2021-326271] [Reference Citation Analysis]
10 Peng Z, Xu D, Li Y, Peng Y, Liu X. Phase Angle as a Comprehensive Tool for Nutritional Monitoring and Management in Patients with Crohn’s Disease. Nutrients 2022;14:2260. [DOI: 10.3390/nu14112260] [Reference Citation Analysis]
11 Agrawal M, Brenner EJ, Yan Mak JW, Zhang X, Kaplan GG, Ng SC, Reinisch W, Steinwurz F, Lewis JD, Kissous-Hunt M, Modesto I, Ungaro RC, Colombel JF, Kappelman MD. COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00599-1. [PMID: 34089848 DOI: 10.1016/j.cgh.2021.05.060] [Reference Citation Analysis]
12 Doubeni CA, Corley DA, Peek RM Jr. Advancing Diversity, Equity, and Inclusion in Scientific Publishing. Gastroenterology 2021:S0016-5085(21)03715-X. [PMID: 34740579 DOI: 10.1053/j.gastro.2021.10.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Feuerstein JD, Ho EY, Shmidt E, Singh H, Falck-Ytter Y, Sultan S, Terdiman JP; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology 2021;160:2496-508. [PMID: 34051983 DOI: 10.1053/j.gastro.2021.04.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Stamatiou D, Naumann DN, Foss H, Singhal R, Karandikar S. Effects of ethnicity and socioeconomic status on surgical outcomes from inflammatory bowel disease. Int J Colorectal Dis 2022. [PMID: 35554640 DOI: 10.1007/s00384-022-04180-0] [Reference Citation Analysis]
15 Singh S, Proctor D, Scott FI, Falck-Ytter Y, Feuerstein JD. AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology 2021;160:2512-2556.e9. [PMID: 34051985 DOI: 10.1053/j.gastro.2021.04.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sedano R, Hogan M, Mcdonald C, Aswani-Omprakash T, Ma C, Jairath V. Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials. Gastroenterology 2021:S0016-5085(21)03585-X. [PMID: 34592174 DOI: 10.1053/j.gastro.2021.09.054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Booth A, Ford W, Brennan E, Magwood G, Forster E, Curran T. Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab237. [PMID: 34553754 DOI: 10.1093/ibd/izab237] [Reference Citation Analysis]
18 Yueying C, Jing F, Tian Y, Yuqi Q, Jun S. Bioelectrical impedance analysis-based nomogram construction for predicting secondary loss of response to infliximab in bio-naïve Crohn's disease patients. Biomed Pharmacother 2021;142:112076. [PMID: 34449314 DOI: 10.1016/j.biopha.2021.112076] [Reference Citation Analysis]
19 Liu JJ. Disparity in the Care of black Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2021:izab100. [PMID: 34037231 DOI: 10.1093/ibd/izab100] [Reference Citation Analysis]
20 Barnes EL, Nowell WB, Venkatachalam S, Dobes A, Kappelman MD. Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Inflamm Bowel Dis 2021:izab219. [PMID: 34473272 DOI: 10.1093/ibd/izab219] [Reference Citation Analysis]